nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A CYP2B6-humanized mouse model and its potential applications
|
Li, Lei |
|
|
33 |
1 |
p. 2-8 |
artikel |
2 |
Appreciation to Reviewers 2017
|
|
|
|
33 |
1 |
p. I |
artikel |
3 |
Chimeric mice with humanized liver: Application in drug metabolism and pharmacokinetics studies for drug discovery
|
Naritomi, Yoichi |
|
|
33 |
1 |
p. 31-39 |
artikel |
4 |
Functional characteristics of a renal H+/lipophilic cation antiport system in porcine LLC-PK1 cells and rats
|
Matsui, Ryutaro |
|
|
33 |
1 |
p. 96-102 |
artikel |
5 |
Functional characterization of 9 CYP2A13 allelic variants by assessment of nicotine C-oxidation and coumarin 7-hydroxylation
|
Kumondai, Masaki |
|
|
33 |
1 |
p. 82-89 |
artikel |
6 |
Genetic variation of cytochrome P450 in Uyghur Chinese population
|
Qi, Guangzhao |
|
|
33 |
1 |
p. 55-60 |
artikel |
7 |
Human and mouse artificial chromosome technologies for studies of pharmacokinetics and toxicokinetics
|
Satoh, Daisuke |
|
|
33 |
1 |
p. 17-30 |
artikel |
8 |
Investigation of the transport of xanthine dehydrogenase inhibitors by the urate transporter ABCG2
|
Nakamura, Makiko |
|
|
33 |
1 |
p. 77-81 |
artikel |
9 |
In vitro inhibitory effects of major bioactive constituents of Andrographis paniculata, Curcuma longa and Silybum marianum on human liver microsomal morphine glucuronidation: A prediction of potential herb-drug interactions arising from andrographolide, curcumin and silybin inhibition in humans
|
Uchaipichat, Verawan |
|
|
33 |
1 |
p. 67-76 |
artikel |
10 |
Organ/body-on-a-chip based on microfluidic technology for drug discovery
|
Kimura, Hiroshi |
|
|
33 |
1 |
p. 43-48 |
artikel |
11 |
Organs-on-a-chip: Current applications and consideration points for in vitro ADME-Tox studies
|
Ishida, Seiichi |
|
|
33 |
1 |
p. 49-54 |
artikel |
12 |
Physiological based pharmacokinetic modeling to estimate in vivo Ki of ketoconazole on renal P-gp using human drug-drug interaction study result of fesoterodine and ketoconazole
|
Oishi, Masayo |
|
|
33 |
1 |
p. 90-95 |
artikel |
13 |
Quantitative analysis of elevation of serum creatinine via renal transporter inhibition by trimethoprim in healthy subjects using physiologically-based pharmacokinetic model
|
Nakada, Tomohisa |
|
|
33 |
1 |
p. 103-110 |
artikel |
14 |
Species differences in drug glucuronidation: Humanized UDP-glucuronosyltransferase 1 mice and their application for predicting drug glucuronidation and drug-induced toxicity in humans
|
Fujiwara, Ryoichi |
|
|
33 |
1 |
p. 9-16 |
artikel |
15 |
State-of-the-art technologies: In vitro and in vivo models mimicking the human drug metabolism and pharmacokinetics
|
Tabata, Kenji |
|
|
33 |
1 |
p. 1 |
artikel |
16 |
Technical aspects of microphysiological systems (MPS) as a promising wet human-in-vivo simulator
|
Kanamori, Toshiyuki |
|
|
33 |
1 |
p. 40-42 |
artikel |
17 |
Terfenadine metabolism of human cytochrome P450 2J2 containing genetic variations (G312R, P351L and P115L)
|
Jeong, Dabin |
|
|
33 |
1 |
p. 61-66 |
artikel |